Register entry
- Registered sites
- 0
- Active NDC listings
- 49
- Labeller names
- 2
- Live patents
- 0
- Countries
- 0
Catalogue
Drug listings by form and route
4949 active NDC listings: 43 human prescription drug, 6 human otc drug. By marketing category: NDA 41, ANDA 6, NDA AUTHORIZED GENERIC 2.
| Dosage form | NDCs |
|---|---|
| capsule | 9 |
| tablet | 9 |
| tablet, film coated | 8 |
| tablet, extended release | 5 |
| cream | 4 |
| tablet, orally disintegrating | 4 |
| kit | 3 |
| aerosol, powder | 2 |
| injection, powder, for solution | 1 |
| injection, powder, lyophilized, for solution | 1 |
| powder, for solution | 1 |
| suspension | 1 |
| tablet, delayed release | 1 |
| Route | NDCs |
|---|---|
| oral | 38 |
| intramuscular | 4 |
| respiratory (inhalation) | 2 |
| topical | 2 |
| vaginal | 2 |
| intravenous | 1 |
| Labeller name on the listing | NDCs |
|---|---|
| h2-pharma, llc | 27 |
| h2-pharma llc | 22 |
Catalogue
Marketed products
49| Brand | Generic name | Form / route | NDC |
|---|---|---|---|
| Bismuth Subcitrate Potassium, Metronidazole and Tetracycline Hydrochloride | Bismuth Subcitrate Potassium, Metronidazole and Tetracycline Hydrochloride | capsule, oral | 61269-386NDA AUTHORIZED GENERIC |
| Childrens Allergy | fexofenadine hydrochloride | suspension, oral | 61269-527ANDA |
| Clotrimazole | Clotrimazole | cream, vaginal | 61269-220ANDA |
| DOCOSANOL | DOCOSANOL | cream, topical | 61269-881ANDA |
| DOCOSANOL | DOCOSANOL | cream, topical | 61269-989ANDA |
| DROXIA | HYDROXYUREA | capsule, oral | 61269-402NDA |
| DROXIA | HYDROXYUREA | capsule, oral | 61269-403NDA |
| DROXIA | HYDROXYUREA | capsule, oral | 61269-404NDA |
| ETOPOPHOS | etoposide phosphate | injection, powder, lyophilized, for solution, intravenous | 61269-410NDA |
| HYDREA | HYDROXYUREA | capsule, oral | 61269-835NDA |
| Klonopin | Clonazepam | tablet, oral | 61269-605NDA |
| Klonopin | Clonazepam | tablet, oral | 61269-610NDA |
| Klonopin | Clonazepam | tablet, oral | 61269-620NDA |
| Miconazole 7 | Miconazole Nitrate | cream, vaginal | 61269-730ANDA |
| ORLISTAT | orlistat | capsule, oral | 61269-565NDA AUTHORIZED GENERIC |
| Omeprazole Delayed release | Omeprazole | tablet, delayed release, oral | 61269-720ANDA |
| PULMICORT FLEXHALER | Budesonide | aerosol, powder, respiratory (inhalation) | 61269-509NDA |
| PULMICORT FLEXHALER | Budesonide | aerosol, powder, respiratory (inhalation) | 61269-518NDA |
| PYLERA | BISMUTH SUBCITRATE POTASSIUM, METRONIDAZOLE, and TETRACYCLINE HYDROCHLORIDE | capsule, oral | 61269-380NDA |
| PYLERA | BISMUTH SUBCITRATE POTASSIUM, METRONIDAZOLE, AND TETRACYCLINE HYDROCHLORIDE | capsule, oral | 61269-381NDA |
| SEROQUEL | quetiapine | tablet, film coated, oral | 61269-250NDA |
| SEROQUEL | quetiapine | tablet, film coated, oral | 61269-251NDA |
| SEROQUEL | quetiapine | tablet, film coated, oral | 61269-252NDA |
| SEROQUEL | quetiapine | tablet, film coated, oral | 61269-253NDA |
| SEROQUEL | quetiapine | tablet, film coated, oral | 61269-254NDA |
| SEROQUEL | quetiapine | tablet, film coated, oral | 61269-255NDA |
| SEROQUEL XR | quetiapine | tablet, extended release, oral | 61269-270NDA |
| SEROQUEL XR | quetiapine | tablet, extended release, oral | 61269-271NDA |
| SEROQUEL XR | quetiapine | tablet, extended release, oral | 61269-272NDA |
| SEROQUEL XR | quetiapine | tablet, extended release, oral | 61269-273NDA |
| SEROQUEL XR | quetiapine | tablet, extended release, oral | 61269-274NDA |
| Valcyte | valganciclovir | tablet, film coated, oral | 61269-480NDA |
| Valcyte | valganciclovir hydrochloride | powder, for solution, oral | 61269-485NDA |
| XELODA | capecitabine | tablet, film coated, oral | 61269-475NDA |
| Xenical | orlistat | capsule, oral | 61269-460NDA |
| ZYPREXA Intramuscular | Olanzapine | injection, powder, for solution, intramuscular | 61269-640NDA |
| ZYPREXA Relprevv | Olanzapine pamoate | kit, intramuscular | 61269-660NDA |
| ZYPREXA Relprevv | Olanzapine pamoate | kit, intramuscular | 61269-661NDA |
| ZYPREXA Relprevv | Olanzapine pamoate | kit, intramuscular | 61269-662NDA |
| ZYPREXA Zydis | Olanzapine | tablet, orally disintegrating, oral | 61269-650NDA |
| ZYPREXA Zydis | Olanzapine | tablet, orally disintegrating, oral | 61269-651NDA |
| ZYPREXA Zydis | Olanzapine | tablet, orally disintegrating, oral | 61269-652NDA |
| ZYPREXA Zydis | Olanzapine | tablet, orally disintegrating, oral | 61269-653NDA |
| Zyprexa | Olanzapine | tablet, oral | 61269-630NDA |
| Zyprexa | Olanzapine | tablet, oral | 61269-631NDA |
| Zyprexa | Olanzapine | tablet, oral | 61269-632NDA |
| Zyprexa | Olanzapine | tablet, oral | 61269-633NDA |
| Zyprexa | Olanzapine | tablet, oral | 61269-634NDA |
| Zyprexa | Olanzapine | tablet, oral | 61269-635NDA |
Compare
Other companies listing olanzapine
- Cardinal Health 418, Inc.34 sites · 833 NDC
- Dr. Reddy's Laboratories Limited15 sites · 683 NDC
- Sun Pharmaceutical Industries Limited13 sites · 918 NDC
- Aurobindo Pharma Limited6 sites · 1,453 NDC
- Teva Pharmaceutical Industries Ltd.6 sites · 668 NDC
- Apotex Inc.6 sites · 372 NDC
- SOLARA ACTIVE PHARMA SCIENCES LIMITED6 sites · 40 NDC
- Pharma Packaging Solutions, LLC dba Tjoapack, LLC5 sites · 667 NDC
- Sandoz Industrial Products S.A5 sites · 441 NDC
- Macleods Pharmaceuticals Limited5 sites · 390 NDC
Enquiry
Common questions
- Is H2-Pharma, LLC FDA approved?
- H2-Pharma, LLC holds no registered establishment of its own; 49 drug products are listed under its name in the National Drug Code Directory, made at sites registered to other firms.
- What drugs does H2-Pharma, LLC make?
- 49 products are listed under H2-Pharma, LLC in the openFDA NDC Directory, most often as capsule; tablet; tablet, film coated. The full breakdown by dosage form and route is above. A listing count is not a sales figure.
Compiled from FDA establishment registrations, the openFDA NDC Directory, the Orange Book and the FDA drug shortage database. Not claimed by the company. Sources and methodology.